Human papillomavirus (HPV) is an extremely common infection that can have serious health consequences, including the development of certain types of cancer. Among these, cervical cancer holds one of the leading positions. However, modern medicine offers a powerful prevention tool — the HPV vaccine. Despite undeniable scientific support and proven efficacy, HPV vaccines are still the subject of debate in society and the media [1]. This article aims to shed light on the importance of HPV vaccination, debunk common myths, and emphasize its role in maintaining health.
What is HPV and why is it dangerous?
Human papillomavirus (HPV) is a group of more than 200 related viruses, some of which are sexually transmitted. Most people become infected with HPV during their lifetime, and in many cases, the immune system successfully handles the virus, clearing the body without any symptoms [3]. However, some types of HPV, known as high-risk (e.g., HPV-16, HPV-18, HPV-31, HPV-33, HPV-45), can cause precancerous changes and, eventually, cancer. The most well-known and common consequence of persistent infection with high-risk HPV types is cervical cancer [4]. In addition, HPV can cause cancer of the vagina, vulva, anus, oropharynx, and penis. There are also low-risk types of HPV (e.g., HPV-6, HPV-11) that cause benign growths, such as genital warts [4].
HPV vaccination: Mechanism of action and proven efficacy
HPV vaccines represent a significant breakthrough in preventive medicine. They are designed to protect against the most dangerous types of the virus responsible for the majority of cancer and precancerous cases. There are different types of vaccines; for example, the bivalent vaccine is effective against HPV-16 and HPV-18, and the quadrivalent vaccine against HPV-6, HPV-11, HPV-16, and HPV-18 [4]. Newer vaccines can protect against an even greater number of HPV types.
Numerous studies confirm the high efficacy of HPV vaccines in preventing infection with targeted HPV types, as well as significantly reducing the incidence of precancerous cervical lesions and other HPV-associated diseases [1, 3]. The optimal age for vaccination is 11-12 years, before the onset of sexual activity, when the immune response is strongest and the probability of contact with the virus is minimal [3]. However, vaccination is also recommended at an older age, up to 45 years, depending on the country and healthcare guidelines.
It is important to note that the vaccine's efficacy is not limited only to the prevention of cervical cancer. It also contributes to a reduction in the incidence of other HPV-related cancers and genital warts [1].
Debunking myths about HPV vaccination
Despite compelling scientific data, HPV vaccination often faces resistance due to common myths and misconceptions. Let's analyze the most frequent ones [3]:
- Myth 1: The vaccine is ineffective in preventing cancer.
Fact: This is false. HPV vaccines are highly effective in preventing infection with those HPV types that cause up to 90% of cervical cancer cases and other HPV-associated cancers. Evidence of its safety and efficacy, extending beyond the prevention of cervical cancer, is constantly accumulating [1, 3]. - Myth 2: Regular PAP tests are sufficient for cervical cancer prevention.
Fact: PAP tests (cytological examination) are an important screening tool that allows for the detection of precancerous changes at early stages. However, a PAP test does not prevent the HPV infection itself. Vaccination, on the other hand, prevents infection, significantly reducing the risk of these changes developing. Vaccination and screening complement each other, providing maximum protection [3]. - Myth 3: The HPV vaccine is unsafe and causes autoimmune diseases.
Fact: The safety of HPV vaccines has been thoroughly studied in numerous trials worldwide. The scientific community and medical organizations unanimously confirm its safety [1, 3]. Reports of a link between HPV vaccination and the development of autoimmune diseases have not found convincing confirmation. Studies show that the population recommended for vaccination has a high risk of developing autoimmune diseases regardless of vaccination, which makes it difficult to establish a causal link [4]. Extensive studies of other vaccines have also not revealed a link to the development or exacerbation of autoimmune conditions, such as multiple sclerosis or myasthenia gravis [5, 6]. - Myth 4: HPV vaccination is not needed because most infections go away on their own.
Fact: Indeed, most HPV infections are cleared by the immune system. However, it is impossible to predict whose infection will progress to a chronic form and lead to cancer. Vaccination provides reliable protection by preventing infection and eliminating this risk [3]. - Myth 5: The age of 11-12 is too young for vaccination.
Fact: This is the optimal age for vaccination. Vaccination before the onset of sexual activity provides maximum protection because the body has not yet encountered the virus, and the immune response to the vaccine is most effective. Furthermore, at this age, children tolerate the vaccine better, and fewer doses are required to form full immunity [3].
There are other barriers to the acceptance of the HPV vaccine, such as its high cost, the perception of HPV as an infection related exclusively to sexual relations, and even low awareness of the risk of cervical cancer in some regions [2, 8].
The role of healthcare professionals and global perspectives
The success of HPV vaccination programs largely depends on the active stance of healthcare professionals. Their recommendations and clear communication with patients and their parents play a key role in increasing vaccination rates [1, 3]. Although HPV vaccination coverage still lags behind other adolescent vaccines (e.g., vaccines against tetanus, diphtheria, pertussis, or meningococcal infection) [3], global efforts to inform and expand access to vaccines continue. Vaccination policy is constantly changing and adapting around the world, taking into account new data and challenges [1].
Discussions about the feasibility of mandatory HPV vaccination, especially for schoolchildren, raise questions about the balance between public health and parental autonomy [2]. However, it is important to separate debates about mandates from questions concerning the vaccine itself. Scientific data unequivocally confirm its safety and efficacy [1].
Conclusion: Protecting future health
HPV vaccination is one of the most significant achievements of modern medicine in the fight against cancer. It offers an unprecedented opportunity to prevent the development of cervical cancer and other HPV-associated diseases. Despite existing myths and concerns, scientific data convincingly prove the safety and high efficacy of the vaccine. Making the decision to vaccinate is an investment in long-term health and well-being. Discuss HPV vaccination with your doctor to get individual recommendations and dispel any doubts.
Sources
- [1] Human Papillomavirus Vaccines: Successes and Future Challenges. https://pubmed.ncbi.nlm.nih.gov/30269207/
- [2] The HPV vaccine mandate controversy. https://pubmed.ncbi.nlm.nih.gov/18082853/
- [3] Addressing HPV vaccine myths: practical information for healthcare providers. https://pubmed.ncbi.nlm.nih.gov/30676241/
- [4] On the relationship between human papilloma virus vaccine and autoimmune diseases. https://pubmed.ncbi.nlm.nih.gov/24468416/
- [5] Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity. https://pubmed.ncbi.nlm.nih.gov/42160053/
- [6] Association between vaccination and myasthenia gravis: a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/41756288/
- [8] Barriers to human papillomavirus vaccine acceptability in Israel. https://pubmed.ncbi.nlm.nih.gov/24229720/
The information provided in this article is for reference purposes only and should not be used for self-diagnosis or self-treatment. Always consult a qualified medical professional for accurate diagnosis, treatment, and individual vaccination recommendations.